跳至主要内容
临床试验/JPRN-UMIN000002837
JPRN-UMIN000002837已完成未知

Safety, efficacy and immunogenicity of autologous tumor lysate-pulsed dendritic cell therapy after resection of stage2A (T2N0,T3N0) esophageal cancer - Autologous tumor lysate-pulsed dendritic cell therapy after resection of esophageal cancer

The University of Tokyo Hospital0 个研究点目标入组 15 人开始时间: 2009年12月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have: -Pulmonary fibrosis or interstitial pneumonia, including their history or predisposition; -Serious drug allergy; -Difficult infections to control; -Serious cardiac diseases; -Active autoimmune diseases; -Other cancers; -Continuous systemic administration of steroids and/or immunosuppressants within 4 weeks.

研究者

相似试验

Safety, efficacy and immunogenicity of autologous... | 临床试验